Development and characterization of ADC999: A novel, potent orally available Wee1 inhibitor with robust antitumor efficacy in vivo

被引：0
|
作者：
Gavory, Gerald
O'Dowd, Colin
Rozycka, Ewelina
Boyd, Caroline
Gorges, Beronia
McLean, Estelle
Daubriac, Julien
Rountree, Shane
Shepherd, Steven
Burton, Stephanie
McFarland, Mary
Treder, Adam
Wilkinson, Andy
Burkamp, Frank
Harrison, Tim
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-LB-319
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-319
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Development of novel, potent orally available Wee1 inhibitors with robust antitumor efficacy in vivo
    Gavory, Gerald
    O'Dowd, Colin
    Rozycka, Ewelina
    Boyd, Caroline
    Gorges, Beronia
    McLean, Estelle
    Rountree, Shane
    Sheperd, Steven
    Burton, Stephanie
    McFarland, Mary
    Janssen, Dominic
    Treder, Adam
    Wilkinson, Andy
    Burkamp, Frank
    Harrison, Tim
    [J]. MOLECULAR CANCER RESEARCH, 2017, 15
  • [2] A novel, potent and selective inhibitor of Wee1 with robust antitumor activity in various cancer xenograph models
    Gavory, Gerald
    O'Dowd, Colin
    Burkamp, Frank
    Rountree, Shane
    Rozycka, Ewelina
    Boyd, Caroline
    Gorges, Beronia
    Burton, Stephanie
    Wilkinson, Andy
    Shepherd, Steven
    Janssen, Dominic
    McFarland, Mary
    Rountree, Shane
    Harrison, Tim
    [J]. CANCER RESEARCH, 2016, 76
  • [3] Design and synthesis of orally available MEK inhibitors with potent in vivo antitumor efficacy
    Adams, Mark E.
    Wallace, Michael B.
    Kanouni, Toufike
    Scorah, Nicholas
    O'Connell, Shawn M.
    Miyake, Hiroshi
    Shi, Lihong
    Halkowycz, Petro
    Zhang, Lilly
    Dong, Qing
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (07) : 2411 - 2414
  • [4] Discovery and development of a potent and highly selective WEE1 inhibitor IMP7068
    Cai, Sui Xiong
    Ma, Ning
    Wang, Xiaozhu
    Jiang, Yangzhen
    Zhang, Hongxia
    Guo, Mingchuan
    Zhou, Ruiyu
    Tian, Ye Edward
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [5] Discovery of potent, selective, and orally available WEE1 inhibitors that demonstrate increased DNA damage and mitosis in tumor cells leading to tumor regression in vivo
    Sun, Shaoxian
    Silvergleid, Sarah
    Gerasyuto, Aleksey I.
    Wang, Jiashi
    Pelletier, Robert D.
    Placzek, Andrew
    Knight, Jennifer L.
    Clark, Anthony
    Wright, Hamish
    Yin, Wu
    Elk, Jackson Chief
    Bell, Jeff
    Bos, Pieter H.
    Boyles, Nicholas A.
    Therrien, Eric
    Jensen, Kristian
    Akinsanya, Karen
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [6] Preclinical in vivo evaluation of a novel treatment strategy combining a Wee1 inhibitor with radiotherapy
    Mason, K.
    Pickett, J.
    Ware, C.
    Hirai, H.
    Strack, P.
    Shumway, S. D.
    Ang, K.
    Buchholz, T. A.
    Milas, L.
    Buser, C. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Puquitinib, a novel orally available PI3K inhibitor, exhibits potent antitumor efficacy against acute myeloid leukemia
    Xie, Chengying
    He, Ye
    Zhen, Mingyue
    Wang, Yulan
    Xu, Yongping
    Lou, Liguang
    [J]. CANCER SCIENCE, 2017, 108 (07): : 1476 - 1484
  • [8] The novel orally available sub-nanomolar potent and selective checkpoint kinase 1 inhibitor CASC-578 is highly active in mantle cell lymphoma as a single agent and in combination with Wee1 inhibition
    Rosler, Robert
    Taylor, Janelle
    Leviten, Dina
    Sierra, Teresa
    Dozier, Ashley
    Klucher, Kevin
    Boyce, Rich
    Boyle, Bob
    Vo, Alex
    Peterson, Scott
    [J]. CANCER RESEARCH, 2017, 77
  • [9] EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity
    Campbell, John E.
    Kuntz, Kevin W.
    Knutson, Sarah K.
    Warholic, Natalie M.
    Keilhack, Heike
    Wigle, Tim J.
    Raimondi, Alejandra
    Klaus, Christine R.
    Rioux, Nathalie
    Yokoi, Akira
    Kawano, Satoshi
    Minoshima, Yukinori
    Choi, Hyeong-Wook
    Scott, Margaret Porter
    Waters, Nigel J.
    Smith, Jesse J.
    Chesworth, Richard
    Moyer, Mikel P.
    Copeland, Robert A.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (05): : 491 - 495
  • [10] Discovery of a Potent, Selective, and Orally Available MTHFD2 Inhibitor (DS18561882) with in Vivo Antitumor Activity
    Kawai, Junya
    Toki, Tadashi
    Ota, Masahiro
    Inoue, Hidekazu
    Takata, Yoshimi
    Asahi, Takashi
    Suzuki, Makoto
    Shimada, Takashi
    Ono, Kaori
    Suzuki, Kanae
    Takaishi, Sachiko
    Ohki, Hitoshi
    Matsui, Satoshi
    Tsutsumi, Shinji
    Hirota, Yasuhide
    Nakayama, Kiyoshi
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (22) : 10204 - 10220
12345